ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,249,903 | +83.8% | 52,188 | +44.5% | 0.06% | +122.2% |
Q1 2023 | $679,891 | -69.0% | 36,126 | -73.7% | 0.03% | -66.2% |
Q4 2022 | $2,189,876 | -48.2% | 137,555 | -46.7% | 0.08% | -46.3% |
Q3 2022 | $4,226,000 | +1610.9% | 258,297 | +1371.3% | 0.15% | +2028.6% |
Q2 2022 | $247,000 | -60.3% | 17,556 | -34.1% | 0.01% | -70.8% |
Q4 2021 | $622,000 | +67.2% | 26,637 | +18.8% | 0.02% | +71.4% |
Q3 2021 | $372,000 | -91.1% | 22,426 | -86.1% | 0.01% | -89.2% |
Q1 2021 | $4,177,000 | +21.8% | 161,892 | +152.4% | 0.13% | +14.0% |
Q4 2020 | $3,429,000 | – | 64,134 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |